Biotechnology News

June 6, 2012

MAYNARD, Mass.--(BUSINESS WIRE)--Allegro Diagnostics is providing an overview of a molecular testing platform for the early detection of lung cancer and its lead genomic test, BronchoGen, at the 2012 BIO International Convention.

June 6, 2012

COLORADO SPRINGS, Colo.--(BUSINESS WIRE)--Dr. Robert Melamede, President and CEO of Cannabis Science (CBIS.OB), will be presenting at the XIX International AIDS Conference (AIDS 2012, www...

June 6, 2012

SALZBURG, Austria--(BUSINESS WIRE)--Sony DADC BioSciences today announced that they were the winner in the category of Best New Company 2012 by Select Biosciences at the 2nd Annual European Life Science Awards that were held in Hamburg. Select...

June 6, 2012

NEEDHAM, Mass.--(BUSINESS WIRE)--Dovetail Health is pleased to announce the additions of Diane Gilworth and Dean McCausland to its senior leadership team. As its new Chief Clinical Officer, Diane Gilworth, RN, NP, MPH, will be responsible for...

June 6, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Catabasis Pharmaceuticals, a clinical stage biopharmaceutical company dedicated to the discovery and development of innovative, effective and safe medicines for the treatment of inflammatory and metabolic...

June 6, 2012

FOSTER CITY, Calif.--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq: GILD) announced today the appointments of Lord Paul Boateng, LLB, member of the United Kingdom House of Lords, and Hannah Kettler, PhD, senior health program officer and...

June 6, 2012

INGELHEIM, Germany--(BUSINESS WIRE)--For Non-US, Non-UK & Non-Canadian Media Only Boehringer Ingelheim has today announced that it has updated the US prescribing information for Pradaxa® (dabigatran etexilate) in alignment with the US Food...

June 6, 2012

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Hyperion Therapeutics, Inc. has announced that its phase II study of glycerol phenylbutyrate, an investigational drug for the treatment of episodic hepatic encephalopathy (HE), met its primary...

June 6, 2012

EXTON, Pa.--(BUSINESS WIRE)--Less than half of patients newly diagnosed with major depressive disorder (MDD) began drug therapy in the first year following diagnosis, according to BioTrends.

June 6, 2012

TORONTO--(BUSINESS WIRE)--The European high-acuity information systems (HAIS) market will undergo a significant downturn in 2012 and 2013 before rebounding by 2015 and 2016.

June 6, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Verastem will present at the Boston CEO Conference June 11-12, 2012.

June 6, 2012

SANTA CLARA, Calif.--(BUSINESS WIRE)--Affymetrix and Massachusetts General Hospital (MGH) to co-develop new cancer biomarker tests using the Affymetrix’ QuantiGene® ViewRNA Assay platform*, an RNA in situ hybridization assay.

June 6, 2012

TEWKSBURY, Mass.--(BUSINESS WIRE)--Cambridge Heart, Inc. (OTCBB: CAMH), a developer of non-invasive diagnostic tests for cardiac disease, today announced that results of a prospective, 155-patient trial reinforce the value of the Microvolt T-Wave...

June 6, 2012

PASADENA, Calif.--(BUSINESS WIRE)--Arrowhead Advances ARC-520 into IND-Enabling Studies for the Treatment of Hepatitis B and Provides Guidance on Development Timeline

June 6, 2012

ST. LOUIS & AARHUS, Denmark--(BUSINESS WIRE)--CLC bio and the International Laboratory for Tropical Agricultural Biotechnology at the Donald Danforth Plant Science Center, collaborate to benefit the Virus Resistant Cassava for Africa project...

June 6, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Stem cell therapeutic and regenerative medicine company, AuxoCell Laboratories, Inc., announces agreement with CordVida, a Brazilian stem cell cryopreservation company.

June 6, 2012

DUBLIN, Ohio--(BUSINESS WIRE)--Navidea Biopharmaceuticals Announces the Presentation of Data at Society of Nuclear Medicine Annual Meeting, June 2012: Clinical trial data from oncology and Alzheimer’s disease product candidates

June 6, 2012

PORTLAND, Ore.--(BUSINESS WIRE)--HemCon Medical Technologies, Inc., an industry leader in hemorrhage control technologies and developer of lyophilized (freeze-dried) human plasma for the U.S. Army, announced today the appointment of Barry...

June 6, 2012

EWING, N.J.--(BUSINESS WIRE)--Antares Pharma, Inc. (NYSE Amex: AIS) today announced that it will voluntarily transfer its stock exchange listing from the NYSE Amex Exchange to the NASDAQ Stock Market LLC. The Company expects trading to commence...

June 6, 2012

HAMILTON, Ontario--(BUSINESS WIRE)--Scientists at McMaster University in Ontario, Canada have discovered a drug, thioridazine, successfully kills cancer stem cells while avoiding the toxic side-effects of conventional cancer treatment.

June 6, 2012

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) today announced that additional safety and efficacy results from its BCX4208 gout program will be presented at the Annual European Congress of...

June 6, 2012

BERLIN--(BUSINESS WIRE)--Eckert & Ziegler obtains manufacturing authorization for pharmaceutical Gallium-68 generators

June 6, 2012

GOETTINGEN, Germany--(BUSINESS WIRE)--Sartorius AG (FWB:SRT), a leading international laboratory and pharmaceutical equipment provider, will be admitted to the TecDAX technology index. This was announced yesterday on Tuesday evening by the German...

June 6, 2012

CAMBRIDGE, England--(BUSINESS WIRE)--Isogenica, Cresset Group and Biolauncher Secure Funding from UK’s Technology Strategy Board for a £1M project to Develop New Small Molecule Drug Platform.

June 6, 2012

WALTHAM, Mass.--(BUSINESS WIRE)--Online evidence-based medical information enhances global health care initiatives in resource-limited settings and improves providers’ knowledge, clinical practice and patient outcomes.

June 6, 2012

HYDERABAD, India--(BUSINESS WIRE)--Dr. Reddy’s Laboratories Ltd. (NYSE:RDY) and Merck Serono, a division of Merck KGaA, Darmstadt, Germany, announced today a partnership to co-develop a portfolio of biosimilar compounds in oncology, primarily...

June 6, 2012

PRINCETON, N.J.--(BUSINESS WIRE)--Bristol-Myers Squibb Company (NYSE: BMY) today announced the results of AMPLE (Abatacept Versus Adalimumab Comparison in Biologic-Naïve rheumatoid arthritis (RA) Subjects With Background Methotrexate), a head-to-...

June 5, 2012

ROCKVILLE, Md.--(BUSINESS WIRE)--Human Genome Sciences, Inc. (Nasdaq: HGSI) announced today that several abstracts related to BENLYSTA® (belimumab) and systemic lupus erythematosus (SLE) will be presented at the EULAR Annual European Congress of...

June 5, 2012

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), today announced data from the ADACTA study which showed that adult rheumatoid arthritis (RA) patients who received ACTEMRA (...

June 5, 2012

BERLIN--(BUSINESS WIRE)--Crescendo Bioscience®, Inc., a molecular diagnostics company, today announced data indicating that the Company’s multi-biomarker blood test, Vectra™ DA, may help identify patients in remission.

June 5, 2012

AIX-EN-PROVENCE, France--(BUSINESS WIRE)--SuperSonic Imagine, the innovative ultrasound imaging company names Kurt Kelln Executive VP of Sales and Marketing and Chief Business Officer. He will direct key strategic & commercial partnerships...

June 5, 2012

WESTON, Mass.--(BUSINESS WIRE)--Biogen Idec Inc. (NASDAQ: BIIB) announced today that its 2012 Analyst Day will be webcast live on Tuesday, June 12, 2012 at 10:00 a.m. ET. To access the live webcast, please visit Biogen Idec’s Investor Relations...

June 5, 2012

SÃO PAULO--(BUSINESS WIRE)--Today, GE Healthcare announced the acquisition of XPRO, a Brazilian Interventional X-ray equipment manufacturer company.

June 5, 2012

WASHINGTON--(BUSINESS WIRE)--The 2012 BIO International Convention will return to Boston, Mass. for the global event for biotechnology, which will take place June 18-21, 2012 at the Boston Convention and Exhibition Center.

June 5, 2012

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Fluxion Biosciences, Inc. today announced an initial agreement to partner with Rubicon Genomics in a reagent supply and collaboration program. The collaboration will integrate enrichment methods for...

June 5, 2012

LOS ANGELES--(BUSINESS WIRE)--KYTHERA Biopharmaceuticals, Inc. (KYTHERA) today announced that it has received a $15.8 million payment from Bayer Consumer Care AG (Bayer) under the terms of their August 2010 collaboration arrangement to develop...

June 5, 2012

FREMONT, Calif.--(BUSINESS WIRE)--DiscoveRx, a leader in innovative cell-based assays for GPCRs, Kinases, NHRs and Proteases, today unveiled a break-through technology called InCELL Hunter™. This platform marks a significant step forward as...

June 5, 2012

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Exelixis, Inc. (NASDAQ:EXEL) today reported positive updated interim data from an ongoing phase 2 trial of cabozantinib in men with metastatic castration-resistant prostate cancer (CRPC) and bone...

June 5, 2012

FARMINGTON, Conn.--(BUSINESS WIRE)--Online learning symposium about laparoscopic liver surgery and pancreatic surgery.

June 5, 2012

WILLOW GROVE, Pa.--(BUSINESS WIRE)--Bill Anderson, pioneer of postmortem toxicology joins NMS Labs

June 5, 2012

LONDON--(BUSINESS WIRE)--New market report "MRI Market in India 2012" elaborated by Netscribes has been recently published by Market Publishers Ltd.

June 5, 2012

INGELHEIM, Germany and INDIANAPOLIS, US--(BUSINESS WIRE)--EX US & UK. Boehringer Ingelheim and Eli Lilly and Company (NYSE: LLY) are pleased to announce that less than two years after forming a strategic alliance aimed at bringing new...

June 5, 2012

CHESHIRE, Conn.--(BUSINESS WIRE)--Alexion Pharmaceuticals, Inc. (Nasdaq: ALXN) today announced that Vikas Sinha, Chief Financial Officer of Alexion Pharmaceuticals, will present at the William Blair & Company 32nd Annual Growth Stock...

June 5, 2012

ANKARA, Turkey--(BUSINESS WIRE)--At the 7th National Molecular and Diagnostic Microbiology Congress in Ankara, Bruker announces an exclusive framework agreement with Düzen (www.duzen.com....

June 5, 2012

BOSTON & GENEVA--(BUSINESS WIRE)--Global ePRO innovator PHT Corp.'s founder Dr. Stephen Raymond and Europe GM Valdo Arnera MD will discuss advances in eClinical research technology at DIA Conference June 24-17, Philadelphia.

June 5, 2012

VAN NUYS, Calif.--(BUSINESS WIRE)--ITT Exelis and Altapure, LLC are launching a new model of their state-of-the-art disinfection system.

June 5, 2012

CHICAGO--(BUSINESS WIRE)--bioTheranostics announced study results showing that its CancerTYPE ID® molecular test helped guide chemotherapy and improve survival for patients with carcinoma of unknown primary site (CUP).

June 5, 2012

BURLINGTON, Mass.--(BUSINESS WIRE)--Decision Resources, one of the world’s leading research and advisory firms for pharmaceutical and healthcare issues, finds that, according to interviewed payers in the EU5 (France, Germany, Italy, Spain and the...